Contents of Kit
1. Divisible microplate: Consisting of 12 modules of 8 wells each. Ready to use. 96 (8×12) wells
2. Calibrators A-F (0, 5, 10, 20, 40, 100 U/mL), containing serum/buffer matrix (PBS, BSA, detergent, NaN3 0.09%), yellow. Ready to use. 1.5 mL × 6
3. Control positive (1) and negative (2), containing PR3 antibodies in a serum/buffer matrix (PBS, BSA, detergent, NaN3 0.09%), yellow, Ready to use. The concentration is specified on the certificate of analysis. 1.5 mL × 2
4. Sample buffer, containing PBS, BSA, detergent, preservative NaN3 0.09%, yellow, 5× conc. 20 mL
5. Enzyme conjugate; containing anti-human IgG antibodies, HRP labelled; PBS, BSA, detergent, preservative ProClin 300 0.05%, light red. Ready to use. 15 mL
6. TMB substrate; containing 3,3',5,5'-Tetramethylbenzidin, colorless. Ready to use. 15 mL
7. Stop solution; contains acid. Ready to use. 15 mL
8. Wash Buffer, containing Tris, detergent, preservative NaN3 0.09%; 50× conc. 20 mL
Storage
Store the kit at 2-8°C in the dark. Do not expose test reagents to heat, sun or strong light during storage and usage. Store microplate sealed and desiccated in the clip bag provided. Unopened reagents are stable until expiration of the kit. See labels for individual batch. Diluted Wash solution and Sample Buffer are stable for at least 30 days when stored at 2-8°C. We recommend consumption on the same day.
Performance Characteristics
Calibration
This assay system is calibrated in relative arbitrary units, since no international reference preparation is available for this assay.
Expected values
In a normal range study with samples from healthy blood donors the following ranges have been established with this ELISA assay: Cut-off 5 U/mL
General Description
Anti-neutrophil cytoplasmic antibodies (ANCA) are diagnostic markers for ANCA-associated vasculitides. Anti-PR3 characterizes granulomatosis with polyangiitis (GPA, formerly: Wegener's granulomatosis). The test supports the differential diagnosis of vasculitis when used in combination with other laboratory and clinical findings.